Macy Burkhart|
Bryan Gross joined the MJ team as the director of compliance regulation and has since climbed the ranks to become the vice president of legal + compliance. In his current capacity, Bryan establishes policies and practices to ensure MJ’s regulatory and contractual compliance, overseeing the legal aspects of our benefits and compliance strategies. As an integral member of MJ’s Senior Leadership Team, he plays a pivotal role in fortifying MJ’s legal foundation and shaping its future.
Remarkable accomplishments punctuate Bryan’s decade-long legal journey. Before joining MJ, he was an associate attorney in Krieg DeVault’s Employee Benefits & Executive Compensation Practice Group. There, Bryan focused on Health & Welfare Employee Benefit Plans, offering legal counsel on complex matters such as benefit plan administration, employment contracts, severance agreements, and organizational policies.
Related Blogs
Health Care Industry Trends to Watch in 2026
The MJ CompaniesHealth care organizations enter 2026 facing numerous operational, financial and liability pressures, including labor shortages, inflation, supply chain volatility and the impact of U.S. ...
Read More
2025 Ended with Softest Market Conditions Since 2017 for all Account Sizes & Majority of Lines of Business, The Council’s P/C Market Survey Shows
The MJ CompaniesThe market appeared to move further into the soft part of the insurance market cycle in Q4 2025. Premiums across all account sizes rose ...
Read More
Miles for Miles Helps People With Intellectual and Developmental Disabilities Thrive
Britni ShroutMiles Peck loves school as much for the chance to spend time with his friends as for the classroom experience. He is bracing his ...
Read More
EBSA Updates National Employee Benefit Plan Enforcement Projects for 2026
DeAnn DeckThe Employee Benefits Security Administration (EBSA) announced updates to its national enforcement projects for fiscal year 2026. According to EBSA, these projects highlight areas ...
Read More
The Hard Market Is Shifting—Here’s What That Means for YOU
Adam AdlerFor years, organizations have been told the same thing at renewal: higher costs, fewer options, and little room to negotiate. Now, that message is ...
Read More
Employer Response to Pharma Shifts
Chris AntypasVolatility in the pharmaceutical industry, including the expanding specialty drug pipeline, increased utilization of GLP-1 medications, and persistent supply chain disruptions, are contributing to rising costs ...
Read More